Pseudomembranous candidiasis by Candida tropicalis in an immunocompromised patient: Case Report.
Abstract
Pseudomembranous candidiasis is the most frequent type of infection by Candida spp., and Candida albicans is the most common species to cause it. Candidiasis can be due to other Candida species less frequently, as is the case of Candida tropicalis a pathogenic species that can cause infection in immunocompromised patients. The aim of this case report is to describe a pathological condition produce by Candida tropicalis.
References
1. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026.
2. Arfiputri DS, Hidayati AN, Handayani S, Ervianti E. Risk factors of vulvovaginal candidiasis in dermato-venereology outpatients clinic of soetomo general hospital, Surabaya, Indonesia. Afr J Infect Dis. 2018;12(1 Suppl):90–4.
3. Carr A, Colley P, Berhe M, Nguyen HL. Evaluating predictors of invasive candidiasis in patients with and without candidemia on micafungin. Proc. 2018;31(1):30–4.
4. Kumari A, Mankotia S, Chaubey B, Luthra M, Singh R. Role of biofilm morphology, matrix content and surface hydrophobicity in the biofilm-forming capacity of various Candida species. J Med Microbiol. 2018:[Epub ahead of print].
5. Castillo GDV, Blanc SL, Sotomayor CE, Azcurra AI. Study of virulence factor of Candida species in oral lesions and its association with potentially malignant and malignant lesions. Arch Oral Biol. 2018;91:35–41.
6. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017;223(9):675–81.
7. Muadcheingka T, Tantivitayakul P. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol. 2015;60(6):894–901.
8. Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016;34(4):487–94.
9. Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol. 2015;6:1391.
10. Spalanzani RN, Mattos K, Marques LI, Barros PFD, Pereira PIP, Paniago AMM, Mendes RP, Chang MR. Clinical and laboratorial features of oral candidiasis in HIV-positive patients. Rev Soc Bras Med Trop. 2018;51(3):352–6.
11. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32(8):1923–9.
12. Zuza-Alves DL, Silva-Rocha WP, Chaves GM. An Update on Candida tropicalis Based on Basic and Clinical Approaches. Front Microbiol. 2017;8:1927.
13. Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G, FUNGEMYCA Study Group. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother. 2012;67(5):1181–7.
14. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol. 2010;48(5):1592–9.
15. Hilgert JB, Giordani JM, de Souza RF, Wendland EM, D'Avila OP, Hugo FN. Interventions for the Management of Denture Stomatitis: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2016;64(12):2539–45.
16. Mothibe JV, Patel M. Pathogenic characteristics of Candida albicans isolated from oral cavities of denture wearers and cancer patients wearing oral prostheses. Microb Pathog. 2017;110:128–34.
17. Khedri S, Santos AL, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Lett Appl Microbiol. 2018;67(4):392–9.
18. Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59(Pt 8):873–80.
19. Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Groß U, Mshana SE. High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals. Int J Infect Dis. 2016;49:185–8.
20. Jordán I, Hernandez L, Balaguer M, López-Castilla JD, Casanueva L, Shuffelman C, García-Teresa MA, de Carlos JC, Anguita P, Aguilar L, ERICAP study group. C. albicans, C. parapsilosis and C. tropicalis invasive infections in the PICU: clinical features, prognosis and mortality. Rev Esp Quimioter. 2014;27(1):56–62.
21. Chandrasekar P, Sirohi `B, Seibel NL, Hsu JW, Azie N, Wu C, Ruhnke M. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia. Mycoses. 2018;61(5):331–6.
2. Arfiputri DS, Hidayati AN, Handayani S, Ervianti E. Risk factors of vulvovaginal candidiasis in dermato-venereology outpatients clinic of soetomo general hospital, Surabaya, Indonesia. Afr J Infect Dis. 2018;12(1 Suppl):90–4.
3. Carr A, Colley P, Berhe M, Nguyen HL. Evaluating predictors of invasive candidiasis in patients with and without candidemia on micafungin. Proc. 2018;31(1):30–4.
4. Kumari A, Mankotia S, Chaubey B, Luthra M, Singh R. Role of biofilm morphology, matrix content and surface hydrophobicity in the biofilm-forming capacity of various Candida species. J Med Microbiol. 2018:[Epub ahead of print].
5. Castillo GDV, Blanc SL, Sotomayor CE, Azcurra AI. Study of virulence factor of Candida species in oral lesions and its association with potentially malignant and malignant lesions. Arch Oral Biol. 2018;91:35–41.
6. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017;223(9):675–81.
7. Muadcheingka T, Tantivitayakul P. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol. 2015;60(6):894–901.
8. Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016;34(4):487–94.
9. Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol. 2015;6:1391.
10. Spalanzani RN, Mattos K, Marques LI, Barros PFD, Pereira PIP, Paniago AMM, Mendes RP, Chang MR. Clinical and laboratorial features of oral candidiasis in HIV-positive patients. Rev Soc Bras Med Trop. 2018;51(3):352–6.
11. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32(8):1923–9.
12. Zuza-Alves DL, Silva-Rocha WP, Chaves GM. An Update on Candida tropicalis Based on Basic and Clinical Approaches. Front Microbiol. 2017;8:1927.
13. Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G, FUNGEMYCA Study Group. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother. 2012;67(5):1181–7.
14. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol. 2010;48(5):1592–9.
15. Hilgert JB, Giordani JM, de Souza RF, Wendland EM, D'Avila OP, Hugo FN. Interventions for the Management of Denture Stomatitis: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2016;64(12):2539–45.
16. Mothibe JV, Patel M. Pathogenic characteristics of Candida albicans isolated from oral cavities of denture wearers and cancer patients wearing oral prostheses. Microb Pathog. 2017;110:128–34.
17. Khedri S, Santos AL, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Lett Appl Microbiol. 2018;67(4):392–9.
18. Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59(Pt 8):873–80.
19. Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Groß U, Mshana SE. High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals. Int J Infect Dis. 2016;49:185–8.
20. Jordán I, Hernandez L, Balaguer M, López-Castilla JD, Casanueva L, Shuffelman C, García-Teresa MA, de Carlos JC, Anguita P, Aguilar L, ERICAP study group. C. albicans, C. parapsilosis and C. tropicalis invasive infections in the PICU: clinical features, prognosis and mortality. Rev Esp Quimioter. 2014;27(1):56–62.
21. Chandrasekar P, Sirohi `B, Seibel NL, Hsu JW, Azie N, Wu C, Ruhnke M. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia. Mycoses. 2018;61(5):331–6.
Published
2018-12-04
How to Cite
OBANDO-PEREDA, Gustavo.
Pseudomembranous candidiasis by Candida tropicalis in an immunocompromised patient: Case Report..
Journal of Oral Research, [S.l.], v. 7, n. 8, p. 327-330, dec. 2018.
ISSN 0719-2479.
Available at: <https://joralres.com/index.php/JOralRes/article/view/joralres.2018.077>. Date accessed: 19 apr. 2024.
doi: https://doi.org/10.17126/joralres.2018.077.
Issue
Section
Cases
Keywords
oral candidiasis; candida tropicalis; immunocompromised host.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2024.
